)
)
COMPASS Pathways Investor Relations Material
Latest events
Q3 2024
COMPASS Pathways
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from COMPASS Pathways Plc
Access all reports
COMPASS Pathways plc, a mental health care company, develops psilocybin therapy through bio-pharmaceutical research. The company conducts a clinical trial on the effectiveness of new therapies for depression; and offers COMP360, a formulation of psilocybin for the treatment-resistant depression. It is also developing COMP515, a formulation of psilocybin for Major Depressive Disorder. COMPASS Pathways plc was founded in 2016 and is headquartered in London, the United Kingdom.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
CMPS
Country
🇺🇸 United States